A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of three doses of topically applied
danazol compared to placebo in subjects with pain associated with fibrocystic breast disease
and to determine the appropriate clinical dose for future studies.